REQUEST A DEMO
Total
USD $0.00
Search more companies

Roche Diagnostics Turkey A.S. (Turkiye)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Roche Diagnostics Turkey Anonim Sirketi Profile Updated: April 27, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Roche Diagnostics Turkey A.S. is based in Turkiye. The head office is in Istanbul. It operates in the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers industry. The company was established on May 24, 1991. The total number of employees is currently 240 (2023). The latest financial highlights indicate a net sales revenue increase of 66.49% in 2021. Its’ total assets recorded a growth of 35.45%. The net profit margin of Roche Diagnostics Turkey A.S. increased by 0.11% in 2021.

Headquarters
Esentepe Mahallesi No:4-5 Kir Gulu Sokak Metrocity Is Merkezi D Blok Apartmani Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Roche Diagnostics Turkey A.S. report to view the information.

Website: http://www.roche.com.tr

Basic Information
Total Employees:
Purchase the Roche Diagnostics Turkey A.S. report to view the information.
Outstanding Shares:
Purchase the Roche Diagnostics Turkey A.S. report to view the information.
Incorporation Date:
May 24, 1991
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Roche Diagnostics Turkey A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
66.49%
Total operating revenue
66.49%
Operating profit (EBIT)
128.01%
Net Profit (Loss) for the Period
76.85%
Total assets
35.45%
Total equity
7.26%
Operating Profit Margin (ROS)
4.94%
Net Profit Margin
0.11%
Return on Equity (ROE)
2.67%
Debt to Equity Ratio
-20.21%
Quick Ratio
0.6%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?